Astrana Health Inc (ASTH) Stock Forecast & Price Target
Astrana Health Inc · NASDAQ
$37.92-0.27 (-0.71%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Astrana Health Inc, 7 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $37.00 to $65.00, a moderate spread. The average target of $47.14 sits 24% above the current $37.92. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 6 to 7 over recent months. On the fundamentals, the Street sees revenue growth near 26% this year and 9% next, consensus EPS building from about $0.79 next quarter toward $3.42 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Strong Buy
Strong Buy00%
Buy7100%
Hold00%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Astrana Health Inc.
As of Jul, 7 of 7 firms rate ASTH a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ASTH EPS & revenue forecast
EPS · NEXT QUARTER
$0.79
Range $0.76 – $0.82 · 2 analysts · +17% YoY
Next period, 2 analysts expect Astrana Health Inc to earn $0.79 a share (range $0.76 – $0.82), versus $0.67 a year earlier. Full-year consensus is $2.92, growing to $3.42 the year after.
REVENUE · NEXT QUARTER
$1.0B
Range $1.0B – $1.1B · 2 analysts · +7% YoY
Revenue is expected to reach $1.0B (range $1.0B – $1.1B), +7.0% year-over-year. Full-year consensus is $4.0B, rising to $4.4B next year.
Top analysts covering Astrana Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ASTH.
#1
David Larsen
BTIG
Buy
$50.00+31.9% to target
Coverage
—
+ Follow
#2
MH
Michael Ha
Baird
Buy
$45.00+18.7% to target
Coverage
—
+ Follow
#3
Ryan Langston
TD Cowen
Buy
$50.00+31.9% to target
Coverage
—
+ Follow
#4
Jailendra Singh
Truist Securities
Buy
$47.00+23.9% to target
Coverage
—
+ Follow
#5
Andrew Mok
Barclays
Buy
$50.00+31.9% to target
Coverage
—
+ Follow
ASTH stock forecast FAQ
What is ASTH's average 12-month price target?+
The 7 analysts with a live target average $47.14 for Astrana Health Inc over the next 12 months, ranging from a $65.00 high to a $37.00 low.
Is ASTH stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 7 analyst ratings, 7 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ASTH?+
The Street-high target is $65.00 (BTIG), and the Street-low is $37.00 (Jefferies). The average of all 7 active targets is $47.14.
How many Wall Street analysts cover ASTH?+
7 analysts have an active rating on Astrana Health Inc, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering ASTH?+
Among analysts who currently cover ASTH, David Larsen of BTIG has the strongest overall Quantellect track record. Their current call is Buy with a $50.00 target.
What is Astrana Health Inc's projected EPS for next quarter?+
The consensus estimate is $0.79 per share (range $0.76 – $0.82) across 2 analysts. Full-year EPS is projected at $2.92, rising to $3.42 the following year.
How much revenue is Astrana Health Inc expected to report next quarter?+
Consensus revenue is $1.0B (range $1.0B – $1.1B). Full-year revenue is projected at $4.0B, growing to $4.4B next year.
Have analysts been upgrading or downgrading ASTH lately?+
As of Jul, 7 of 7 firms rate ASTH a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ASTH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
BTIG
